A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically used for people who already have cardiovascular disease, can ...

A powerful new treatment has emerged in efforts to reduce high cholesterol levels and the associated risk of heart health problems. In a new trial, the drug enlicitide decanoate was found to lower ...

Add Yahoo as a preferred source to see more of our stories on Google. Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, ...

By Christy Santhosh March 30 (Reuters) - Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully ...

A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...

An experimental tablet taken once a day has cut levels of 'bad' cholesterol by around 60% and could save millions from heart ...

Earlier use of cholesterol lowring drug evolocumab may reduce heart attack and stroke risk in high-risk diabetes patients without known heart disease.

A new experimental pill may soon change how doctors treat high cholesterol and prevent heart disease. In a large clinical ...

Merck & Co.’s experimental cholesterol pill slashed levels of the artery-clogging plaque far more than older tablets in the ...

US health guidelines say people should start having their levels tested from the age of 30 ...

The new oral pill enlicitide cuts bad cholesterol risk by 60% in a new landmark trial. Here are the mechanisms behind it and ...